Company news
Gemina Laboratories Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Gemina Announces Private Placement Offering
July 13, 2026
Gemina Laboratories Ltd. Announces Delisting from the CSE
March 25, 2026
Debenture Offering and Delisting
December 30, 2025
Gemina Laboratories Announces Termination of Transaction
October 1, 2025
CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING
September 18, 2025
Gemina Laboratories Announces Private Placement
November 13, 2024
Gemina Laboratories Strategic Update
July 10, 2024
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
June 20, 2024
Gemina Labs Announces Addition to its IP Portfolio
April 9, 2024
Gemina Laboratories Sign First Strategic License Agreement
April 2, 2024
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
March 21, 2024
Gemina Announces Closing of $910,000 Convertible Note Financing
March 19, 2024
Gemina Labs Ltd Appoints Stifel as Financial Advisor
November 6, 2023
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
July 25, 2023
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
June 15, 2023
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
June 5, 2023
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
May 17, 2023
Gemina Laboratories to Host Investor Webinar on March 30, 2023
March 27, 2023
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
March 7, 2023
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
January 25, 2023
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
January 23, 2023
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
January 10, 2023
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
January 6, 2023
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 7, 2022
Gemina Labs Enters into Licence and Manufacturing Agreements
October 6, 2022
Gemina Labs Presents at the H.C. Wainwright Global Investment Conference
September 12, 2022
Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer
September 6, 2022
Gemina Labs Announces Closing Of Concurrent Private Placement
July 11, 2022
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
June 30, 2022
Gemina Announces Filing of Prospectus Supplement
June 24, 2022
Gemina Announces Proposed Financing Up to $5 Million
June 21, 2022
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
June 8, 2022
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test
May 17, 2022
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
May 5, 2022
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
April 28, 2022
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
March 31, 2022
Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
February 23, 2022
Gemina Labs Strategic Update: From Product to Platform, Gemina Provides a Technology Roadmap
February 15, 2022
Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
February 3, 2022
Gemina Labs Announces Appointment Of Senior Scientific Adviser
November 18, 2021
Gemina Labs Announces Closing of Oversubscribed Private Placement
October 25, 2021
Gemina Labs Announces Private Placement
October 20, 2021
Gemina Labs Receives Positive Initial Manufacturing Results for SARS-CoV-2 Diagnostic Test
September 20, 2021
Gemina Labs Provides Research and Development and Corporate Update
September 13, 2021
Gemina Labs Announces Research and Development Appointments
August 30, 2021
Gemina Labs Announces Listing on the Canadian Securities Exchange
August 10, 2021